A meta-analysis of biological variation in blood-based therapy as a precursor to bio-manufacturing

Currently cellular therapies, such as hematopoietic stem cell transplantation (HSCT), are produced at a small scale on a case-by-case basis, usually in a clinical or near-clinical setting. Meeting the demand for future cellular therapies will require a robust and scalable manufacturing process that...

Full description

Saved in:
Bibliographic Details
Main Authors: Jamie Thurman-Newell, Jon Petzing, David Williams
Format: Default Article
Published: 2016
Subjects:
Mechanical engineering not elsewhere classified
Biological variation
Blood
HSCT
Process design
Quality control
Mechanical Engineering not elsewhere classified
Online Access:https://hdl.handle.net/2134/21083
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items